Emma R. Woodward - Search Results

Year	Number of Results
2004	1
2006	1
2007	2
2008	2
2010	2
2011	1
2012	1
2013	3
2014	1
2015	2
2016	2
2017	5
2018	5
2019	6
2020	16
2021	23
2022	18
2023	19
2024	5

1

Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants.

Zhang Z, Ye S, Bernhardt SM, Nelson HD, Velie EM, Borges VF, Woodward ER, Evans DGR, Schedin PJ. Zhang Z, et al. Among authors: woodward er. JAMA Netw Open. 2024 Apr 1;7(4):e247421. doi: 10.1001/jamanetworkopen.2024.7421. JAMA Netw Open. 2024. PMID: 38639936 Free PMC article.

2

Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2.

Evans DG, Burghel GJ, Howell SJ, Pugh S, Forde C, Howell A, Lalloo F, Woodward ER. Evans DG, et al. J Med Genet. 2024 Apr 12:jmg-2023-109826. doi: 10.1136/jmg-2023-109826. Online ahead of print. J Med Genet. 2024. PMID: 38609177

3

Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.

Evans DG, Green K, Burghel GJ, Forde C, Lalloo F, Schlecht H, Woodward ER. Evans DG, et al. Among authors: woodward er. Fam Cancer. 2024 Mar 13. doi: 10.1007/s10689-024-00360-9. Online ahead of print. Fam Cancer. 2024. PMID: 38478259

4

Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol.

Dixon-Zegeye M, Shaw R, Collins L, Perez-Smith K, Ooms A, Qiao M, Pantziarka P, Izatt L, Tischkowitz M, Harrison RE, George A, Woodward ER, Lord S, Hawkes L, Evans DG, Franklin J, Hanson H, Blagden SP. Dixon-Zegeye M, et al. Among authors: woodward er. Trials. 2024 Feb 3;25(1):103. doi: 10.1186/s13063-024-07929-w. Trials. 2024. PMID: 38308321 Free PMC article.

5

Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer.

Morgan RD, Burghel GJ, Schlecht H, Clamp AR, Hasan J, Mitchell CL, Salih Z, Shaw J, Desai S, Jayson GC, Woodward ER, Evans DGR. Morgan RD, et al. Among authors: woodward er. Cancers (Basel). 2023 Dec 29;16(1):177. doi: 10.3390/cancers16010177. Cancers (Basel). 2023. PMID: 38201604 Free PMC article.

6

Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400.

Woodward ER, Lalloo F, Forde C, Pugh S, Burghel GJ, Schlecht H, Harkness EF, Howell A, Howell SJ, Gandhi A, Evans DG. Woodward ER, et al. J Med Genet. 2024 Mar 21;61(4):385-391. doi: 10.1136/jmg-2023-109671. J Med Genet. 2024. PMID: 38123987

7

Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.

Roberts E, van Veen EM, Byers H, Barnett-Griness O, Gronich N, Lejbkowicz F, Pinchev M, Smith MJ, Howell A, Newman WG, Woodward ER, Harkness EF, Brentnall AR, Cuzick J, Rennert G, Howell SJ, Gareth Evans D. Roberts E, et al. Among authors: woodward er. Genet Med. 2023 Oct;25(10):100963. doi: 10.1016/j.gim.2023.100963. Epub 2023 Aug 30. Genet Med. 2023. PMID: 37650883 Free article. No abstract available.

8

Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome.

Lalloo F, Kulkarni A, Chau C, Nielsen M, Sheaff M, Steele J, van Doorn R, Wadt K, Hamill M, Torr B, Tischkowitz M; Delphi respondents; Hanson H. Lalloo F, et al. Eur J Hum Genet. 2023 Nov;31(11):1261-1269. doi: 10.1038/s41431-023-01448-z. Epub 2023 Aug 22. Eur J Hum Genet. 2023. PMID: 37607989 Free PMC article.

9

Hereditary renal cancer patient and public involvement group: A collaborative, consensus decision process to develop a communication tool for patient use.

Colvin E, Ng S, Hepworth J, Hepworth J, Hartley T, Godfrey N, Tricker K, Rothwell J, Beaman G, Woodward ER. Colvin E, et al. Among authors: woodward er. J Clin Transl Sci. 2023 Mar 27;7(1):e115. doi: 10.1017/cts.2023.39. eCollection 2023. J Clin Transl Sci. 2023. PMID: 37250990 Free PMC article.

10

TP53 c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcoma.

Evans DG, Harkness EF, Woodward ER. Evans DG, et al. Among authors: woodward er. J Med Genet. 2023 Nov;60(11):1057-1060. doi: 10.1136/jmg-2022-109133. Epub 2023 Apr 19. J Med Genet. 2023. PMID: 37076289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year